CLINICAL_TRIALS
trial_result
· 2020-08-07
Clinical Trial Update: Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct [Phase 2]
Summary
A Phase 2 clinical trial evaluating rosuvastatin as an adjunct to standard therapy for pulmonary tuberculosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National University Hospital, Singapore | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: UNKNOWN